Antibacterial Characterization of Novel Synthetic Thiazole Compounds Against Methicillin-Resistant Staphylococcus Pseudintermedius

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2015 Jun 19

PMID 26086336

Citations 27

Authors

Haroon Mohammad

P V Narasimha Reddy

Dennis Monteleone

Abdelrahman S Mayhoub

Mark Cushman

G Kenitra Hammac

Mohamed N Seleem

Affiliations

Soon will be listed here.

Abstract

Staphylococcus pseudintermedius is a commensal organism of companion animals that is a significant source of opportunistic infections in dogs. With the emergence of clinical isolates of S. pseudintermedius (chiefly methicillin-resistant S. pseudintermedius (MRSP)) exhibiting increased resistance to nearly all antibiotic classes, new antimicrobials and therapeutic strategies are urgently needed. Thiazole compounds have been previously shown to possess potent antibacterial activity against multidrug-resistant strains of Staphylococcus aureus of human and animal concern. Given the genetic similarity between S. aureus and S. pseudintermedius, this study explores the potential use of thiazole compounds as novel antibacterial agents against methicillin-sensitive S. pseudintermedius (MSSP) and MRSP. A broth microdilution assay confirmed these compounds exhibit potent bactericidal activity (at sub-microgram/mL concentrations) against both MSSA and MRSP clinical isolates while the MTS assay confirmed three compounds (at 10 μg/mL) were not toxic to mammalian cells. A time-kill assay revealed two derivatives rapidly kill MRSP within two hours. However, this rapid bactericidal activity was not due to disruption of the bacterial cell membrane indicating an alternative mechanism of action for these compounds against MRSP. A multi-step resistance selection analysis revealed compounds 4 and 5 exhibited a modest (two-fold) shift in activity over ten passages. Furthermore, all six compounds (at a subinihibitory concentration) demonstrated the ability to re-sensitize MRSP to oxacillin, indicating these compounds have potential use for extending the therapeutic utility of β-lactam antibiotics against MRSP. Metabolic stability analysis with dog liver microsomes revealed compound 3 exhibited an improved physicochemical profile compared to the lead compound. In addition to this, all six thiazole compounds possessed a long post-antibiotic effect (at least 8 hours) against MRSP. Collectively the present study demonstrates these synthetic thiazole compounds possess potent antibacterial activity against both MSSP and MRSP and warrant further investigation into their use as novel antimicrobial agents.

Citing Articles

Antimicrobial Strategies Proposed for the Treatment of and Other Dermato-Pathogenic spp. in Companion Animals: A Narrative Review.

Stefanetti V, Passamonti F, Rampacci E Vet Sci. 2024; 11(7).

PMID: 39057995 PMC: 11281426. DOI: 10.3390/vetsci11070311.

Synthesis and structure-activity relationship of novel thiazole aminoguanidines against MRSA and .

Yang P, Liu H, Wang Y, Qi H, Wang L, Wang B RSC Med Chem. 2024; 15(3):1003-1014.

PMID: 38516595 PMC: 10953494. DOI: 10.1039/d4md00017j.

Antimicrobial Activity of Novel Ni(II) and Zn(II) Complexes with (E)-2-((5-Bromothiazol-2-yl)imino)methyl)phenol Ligand: Synthesis, Characterization and Molecular Docking Studies.

Al-Qadsy I, Saeed W, Al-Owais A, Semlali A, Alrabie A, Al-Faqeeh L Antibiotics (Basel). 2023; 12(11).

PMID: 37998835 PMC: 10669075. DOI: 10.3390/antibiotics12111634.

Naphthylthiazoles: a class of broad-spectrum antifungals.

Hagras M, Abutaleb N, Ezzat H, Salama E, Seleem M, Mayhoub A RSC Med Chem. 2023; 14(10):2089-2099.

PMID: 37859711 PMC: 10583822. DOI: 10.1039/d3md00323j.

Synthesis, Antioxidant, and Antifungal Activities of β-Ionone Thiazolylhydrazone Derivatives and Their Application in Anti-Browning of Freshly Cut Potato.

Huang C, Zhong Y, Zeng R, Wang J, Fang Q, Xiao S Molecules. 2023; 28(18).

PMID: 37764489 PMC: 10537339. DOI: 10.3390/molecules28186713.

References

May E . Bacterial skin diseases: current thoughts on pathogenesis and management. Vet Clin North Am Small Anim Pract. 2005; 36(1):185-202, viii. DOI: 10.1016/j.cvsm.2005.09.014. View

Furlani R, Yeagley A, Melander C . A flexible approach to 1,4-di-substituted 2-aminoimidazoles that inhibit and disperse biofilms and potentiate the effects of β-lactams against multi-drug resistant bacteria. Eur J Med Chem. 2013; 62:59-70. DOI: 10.1016/j.ejmech.2012.12.005. View

Su Z, Peng L, Worthington R, Melander C . Evaluation of 4,5-disubstituted-2-aminoimidazole-triazole conjugates for antibiofilm/antibiotic resensitization activity against MRSA and Acinetobacter baumannii. ChemMedChem. 2011; 6(12):2243-51. DOI: 10.1002/cmdc.201100316. View

Eckholm N, Outerbridge C, White S, Sykes J . Prevalence of and risk factors for isolation of meticillin-resistant Staphylococcus spp. from dogs with pyoderma in northern California, USA. Vet Dermatol. 2013; 24(1):154-61.e34. DOI: 10.1111/j.1365-3164.2012.01051.x. View

Mohammad H, Mayhoub A, Ghafoor A, Soofi M, Alajlouni R, Cushman M . Discovery and characterization of potent thiazoles versus methicillin- and vancomycin-resistant Staphylococcus aureus. J Med Chem. 2014; 57(4):1609-15. PMC: 4353699. DOI: 10.1021/jm401905m. View

Geoghegan J, Smith E, Speziale P, Foster T . Staphylococcus pseudintermedius expresses surface proteins that closely resemble those from Staphylococcus aureus. Vet Microbiol. 2009; 138(3-4):345-52. DOI: 10.1016/j.vetmic.2009.03.030. View

Su Z, Yeagley A, Su R, Peng L, Melander C . Structural studies on 4,5-disubstituted 2-aminoimidazole-based biofilm modulators that suppress bacterial resistance to β-lactams. ChemMedChem. 2012; 7(11):2030-9. DOI: 10.1002/cmdc.201200350. View

Giguere S, Lee E, Guldbech K, Berghaus L . In vitro synergy, pharmacodynamics, and postantibiotic effect of 11 antimicrobial agents against Rhodococcus equi. Vet Microbiol. 2012; 160(1-2):207-13. DOI: 10.1016/j.vetmic.2012.05.031. View

Mohammad H, Reddy P, Monteleone D, Mayhoub A, Cushman M, Seleem M . Synthesis and antibacterial evaluation of a novel series of synthetic phenylthiazole compounds against methicillin-resistant Staphylococcus aureus (MRSA). Eur J Med Chem. 2015; 94:306-16. PMC: 4716659. DOI: 10.1016/j.ejmech.2015.03.015. View

10.

Baldoni D, Furustrand Tafin U, Aeppli S, Angevaare E, Oliva A, Haschke M . Activity of dalbavancin, alone and in combination with rifampicin, against meticillin-resistant Staphylococcus aureus in a foreign-body infection model. Int J Antimicrob Agents. 2013; 42(3):220-5. DOI: 10.1016/j.ijantimicag.2013.05.019. View

11.

ONeill A, Miller K, Oliva B, Chopra I . Comparison of assays for detection of agents causing membrane damage in Staphylococcus aureus. J Antimicrob Chemother. 2004; 54(6):1127-9. DOI: 10.1093/jac/dkh476. View

12.

Murugaiyan J, Walther B, Stamm I, Abou-Elnaga Y, Brueggemann-Schwarze S, Vincze S . Species differentiation within the Staphylococcus intermedius group using a refined MALDI-TOF MS database. Clin Microbiol Infect. 2014; 20(10):1007-15. DOI: 10.1111/1469-0691.12662. View

13.

Farrell D, Robbins M, Rhys-Williams W, Love W . Investigation of the potential for mutational resistance to XF-73, retapamulin, mupirocin, fusidic acid, daptomycin, and vancomycin in methicillin-resistant Staphylococcus aureus isolates during a 55-passage study. Antimicrob Agents Chemother. 2010; 55(3):1177-81. PMC: 3067113. DOI: 10.1128/AAC.01285-10. View

14.

PAGET C, Kisner K, Stone R, DELONG D . Heterocyclic substituted ureas. II. Immunosuppressive and antiviral activity of benzothiazole- and benzoxazoleureas. J Med Chem. 1969; 12(6):1016-8. DOI: 10.1021/jm00306a011. View

15.

Bastos M, Coutinho B, Coelho M . Lysostaphin: A Staphylococcal Bacteriolysin with Potential Clinical Applications. Pharmaceuticals (Basel). 2016; 3(4):1139-1161. PMC: 4034026. DOI: 10.3390/ph3041139. View

16.

Beco L, Guaguere E, Lorente Mendez C, Noli C, Nuttall T, Vroom M . Suggested guidelines for using systemic antimicrobials in bacterial skin infections: part 2-- antimicrobial choice, treatment regimens and compliance. Vet Rec. 2013; 172(6):156-60. PMC: 3582090. DOI: 10.1136/vr.101070. View

17.

Milani C, Corro M, Drigo M, Rota A . Antimicrobial resistance in bacteria from breeding dogs housed in kennels with differing neonatal mortality and use of antibiotics. Theriogenology. 2012; 78(6):1321-8. DOI: 10.1016/j.theriogenology.2012.05.033. View

18.

Vannuffel P, Gigi J, Ezzedine H, Vandercam B, Delmee M, Wauters G . Specific detection of methicillin-resistant Staphylococcus species by multiplex PCR. J Clin Microbiol. 1995; 33(11):2864-7. PMC: 228596. DOI: 10.1128/jcm.33.11.2864-2867.1995. View

19.

Baldoni D, Haschke M, Rajacic Z, Zimmerli W, Trampuz A . Linezolid alone or combined with rifampin against methicillin-resistant Staphylococcus aureus in experimental foreign-body infection. Antimicrob Agents Chemother. 2008; 53(3):1142-8. PMC: 2650529. DOI: 10.1128/AAC.00775-08. View

20.

Orhan G, Bayram A, Zer Y, Balci I . Synergy tests by E test and checkerboard methods of antimicrobial combinations against Brucella melitensis. J Clin Microbiol. 2005; 43(1):140-3. PMC: 540140. DOI: 10.1128/JCM.43.1.140-143.2005. View